Spyre Therapeutics, Inc. (SYRE)
41.04
-1.45
(-3.41%)
USD |
NASDAQ |
Mar 03, 14:09
Spyre Therapeutics Shareholders Equity (Quarterly) : 715.24M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 280.51M |
| PTC Therapeutics, Inc. | -205.31M |
| Agios Pharmaceuticals, Inc. | 1.193B |
| Tandem Diabetes Care, Inc. | 155.17M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 777.78M |
| Total Liabilities (Quarterly) | 62.54M |
| Current Ratio | 13.25 |